- Last edited on June 7, 2023
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision | ||
meds:dopamine-agonists:pramipexole [on May 16, 2019] |
meds:dopamine-agonists:pramipexole [on April 25, 2020] |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== Pramipexole ====== | ====== Pramipexole ====== | ||
+ | {{INLINETOC}} | ||
===== Primer ==== | ===== Primer ==== | ||
**Pramipexole** (Tradename: //Mirapex//) is a dopamine agonist used in the treatment of [[geri:parkinsons|]] and [[sleep:parasomnias:rls|restless legs syndrome]]. | **Pramipexole** (Tradename: //Mirapex//) is a dopamine agonist used in the treatment of [[geri:parkinsons|]] and [[sleep:parasomnias:rls|restless legs syndrome]]. | ||
+ | |||
+ | * It is a D2 receptor agonist and also has receptor selectivity for the D3 receptor subtype of the D2 subfamily of receptors. | ||
==== Side Effects ==== | ==== Side Effects ==== | ||
There is the potential to cause compulsive behaviours and sudden sleep attacks.[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116443/|Homann, C. N., Wenzel, K., Suppan, K., Ivanic, G., Kriechbaum, N., Crevenna, R., & Ott, E. (2002). Sleep attacks in patients taking dopamine agonists. Bmj, 324(7352), 1483-1487.]])] | There is the potential to cause compulsive behaviours and sudden sleep attacks.[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116443/|Homann, C. N., Wenzel, K., Suppan, K., Ivanic, G., Kriechbaum, N., Crevenna, R., & Ott, E. (2002). Sleep attacks in patients taking dopamine agonists. Bmj, 324(7352), 1483-1487.]])] |